Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$656M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$612M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$353M |
| 5 |
Walmart
WMT
|
+$316M |
Top Sells
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
PepsiCo
PEP
|
+$394M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$248M |
| 4 |
Philip Morris
PM
|
+$246M |
| 5 |
Eli Lilly
LLY
|
+$240M |
Sector Composition
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARCE
1751
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $5.38M | ﹤0.01% |
106,200
+97,600
| +1,135% | +$4.95M |
|
|
CBPX
1752
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $5.38M | ﹤0.01% |
197,200
-772
| -0.4% | -$21.1K |
|
|
CRR
1753
DELISTED
Carbo Ceramics Inc.
CRR
| $5.38M | ﹤0.01% |
2,239,854
+153,026
| +7% | +$367K |
|
|
STAY
1754
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $5.36M | ﹤0.01% |
365,801
-646,799
| -64% | -$9.47M |
|
1755
Endava
DAVA
$537M
| $5.35M | ﹤0.01% |
141,460
+40,560
| +40% | +$1.54M |
|
1756
Invesco Preferred ETF
PGX
$3.99B
| $5.35M | ﹤0.01% |
356,396
+276,696
| +347% | +$4.16M |
|
1757
Bankwell Financial Group
BWFG
$359M
| $5.35M | ﹤0.01% |
194,400
-200
| -0.1% | -$5.5K |
|
1758
Western Alliance Bancorporation
WAL
$9.77B
| $5.34M | ﹤0.01% |
115,804
-4,900
| -4% | -$226K |
|
|
BBU
1759
Brookfield Business Partners
BBU
$2.4B
| $5.33M | ﹤0.01% |
211,810
+137,416
| +185% | +$3.46M |
|
|
LGF.B
1760
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $5.32M | ﹤0.01% |
608,493
+214,793
| +55% | +$1.88M |
|
1761
BHP
BHP
$137B
| $5.3M | ﹤0.01% |
120,395
-160,752
| -57% | -$7.08M |
|
1762
Fastenal
FAST
$54.5B
| $5.3M | ﹤0.01% |
324,376
+235,400
| +265% | +$3.85M |
|
1763
Vanguard FTSE Emerging Markets ETF
VWO
$100B
| $5.27M | ﹤0.01% |
+131,000
| New | +$5.27M |
|
|
DERM
1764
DELISTED
Dermira, Inc.
DERM
| $5.27M | ﹤0.01% |
825,198
+409,098
| +98% | +$2.61M |
|
1765
Roku
ROKU
$13.9B
| $5.26M | ﹤0.01% |
51,698
-2,064,102
| -98% | -$210M |
|
|
CBD
1766
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $5.23M | ﹤0.01% |
272,000
-84,600
| -24% | -$1.63M |
|
1767
V2X
VVX
$1.7B
| $5.23M | ﹤0.01% |
128,600
-24,800
| -16% | -$1.01M |
|
1768
BRF SA
BRFS
$6.22B
| $5.22M | ﹤0.01% |
569,560
-625,300
| -52% | -$5.73M |
|
|
INVX
1769
Innovex International, Inc.
INVX
$1.14B
| $5.21M | ﹤0.01% |
103,900
+88,100
| +558% | +$4.42M |
|
1770
Esperion Therapeutics
ESPR
$573M
| $5.2M | ﹤0.01% |
141,900
-95,600
| -40% | -$3.5M |
|
|
ITI
1771
DELISTED
Iteris, Inc.
ITI
| $5.2M | ﹤0.01% |
904,774
+145,374
| +19% | +$835K |
|
1772
Orion Energy Systems
OESX
$31.4M
| $5.19M | ﹤0.01% |
181,976
+18,582
| +11% | +$530K |
|
1773
Nexa Resources
NEXA
$657M
| $5.18M | ﹤0.01% |
550,100
+32,000
| +6% | +$301K |
|
1774
AtriCure
ATRC
$1.74B
| $5.18M | ﹤0.01% |
207,500
+32,259
| +18% | +$805K |
|
|
FPRX
1775
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $5.17M | ﹤0.01% |
1,334,891
+185,691
| +16% | +$720K |
|